Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00766948 · ClinicalTrials.gov registry record
The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry
A clinical trial of Parkinson's Disease, sponsored by Scripps Translational Science Institute.
- Active
- Registry status
- 100
- Enrollment target
- 3
- Study locations
NCT00766948: Active study of Parkinson's Disease, sponsored by Scripps Translational Science Institute.
NCT00766948 is a study of Parkinson's Disease that is active but no longer recruiting, run by Scripps Translational Science Institute. The registered enrollment target is 100 participants, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (84% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00766948, a study of Parkinson's Disease, is active but no longer recruiting, sponsored by Scripps Translational Science Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 3
- Study locations
Study Summary
By creating a neurogenebank from Parkinson's disease patients' blood donations we will ultimately be able to define genes for Parkinson's disease and other neurological conditions.
Primary Outcome
initiate a Parkinson's disease neurogenetic databank by obtaining blood samples in order to define genes for Parkinson's disease and other neurological conditions.
Conditions Studied
Interventions
- OTHER There is no intervention, this is a biorepository.
Study Locations (3)
California
- Scripps Clinic, Torrey Pines - La Jolla
- Scripps Translational Science Institute - La Jolla
- The Scripps Research Institute - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2008-08 |
| Est. Completion | 2030-08 |
What the registry record for NCT00766948 still lists
NCT00766948 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 1 intervention - of which There is no intervention, this is a biorepository. is the first listed.
NCT00766948 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00766948 about?
NCT00766948 is a clinical study titled "The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry". By creating a neurogenebank from Parkinson's disease patients' blood donations we will ultimately be able to define genes for Parkinson's disease and other neurological conditions.
What is the current status of trial NCT00766948?
This trial is currently active not recruiting. The enrollment target is 100 participants. The study started on 2008-08. Estimated completion is 2030-08.
What conditions does trial NCT00766948 study?
This clinical trial studies the following conditions: Parkinson's Disease.
What interventions are being tested in trial NCT00766948?
The interventions under investigation include: There is no intervention, this is a biorepository. (OTHER).
Who is sponsoring clinical trial NCT00766948?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00766948 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00766948's enrollment target sits among peer trials
100 55th of 158 higher than 100 of 158 other Parkinson's Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease
RECRUITING · NA
-
rTMS to Improve Cognition in Parkinson's
RECRUITING · Phase 1
-
Deep Brain Stimulation for Visuomotor Function in Parkinson's Disease
RECRUITING
-
Ketamine for Veterans With Parkinson's Disease
RECRUITING · Phase 2
-
Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease
RECRUITING · NA
-
PET Imaging Evaluation of [11C]SY08
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia